Sullivan becomes CBO at Prilenia 

Neurodegenerative and neurodevelopmental disorder company Prilenia Therapeutics B.V. named Anne Sullivan as CBO.  Sullivan was CBO at Rodin Therapeutics Inc., a neurology company that was acquired by Alkermes plc (NASDAQ:ALKS).

Mark Frattini became CMO at Cellectis S.A. (NASDAQ:CLLS; Euronext:ALCLS), a gene editing platform company. Frattini joined Cellectis in August 2020 as SVP of clinical sciences; before that he was executive medical director, program lead, global clinical R&D at Celgene Corp. and Bristol Myers Squibb Co. (NYSE:BMY)...